Page 74 - 《南京医科大学学报》自然科学版2026年第2期
P. 74

第46卷第2期
               ·230 ·                            南 京    医 科 大 学 学         报                        2026年2月


                   change and percentage of average annual change in ana⁃  infection[J]. Journal of Kunming Medical University,
                   lyzing trends of change in medical research[J]. Chinese  2020,41(9):107-113
                   Journal of Health Statistics,2022,39(3):470-473  [18]陆彦盟,李仕雄,向文耀,等. 医院丙肝微消除模式的建
             [10]SUN N,HE F L,SUN J F,et al. Viral hepatitis in China  立与应用成效[J]. 现代医院,2024,24(4):651-653
                   during 2002 ⁃ 2021:epidemiology and influence factors  LU Y M,LI S X,XIANG W Y,et al. Establishment and
                   through a country⁃level modeling study[J]. BMC Public  application effectiveness of a hospital⁃based micro⁃elimi⁃
                   Health,2024,24(1):1820-1820                       nation model for hepatitis C[J]. Modern Hospitals,2024,
             [11]黎    舒,邱    媛,何    波,等. 基于 SaTScan 的 2017—          24(4):651-653
                   2021 年南宁市耐多药肺结核疫情时空分析[J]. 公共                 [19]陈沄渟,史灵恩,卢        静,等. 江苏省丙型肝炎哨点监测
                   卫生与预防医学,2024,35(2):17-20                          分析[J]. 中国艾滋病性病,2024,30(7):727-731
                   LI S,QIU Y,HE B,et al. Spatiotemporal analysis of mul⁃  CHEN Y T,SHI L E,LU J,et al. Analysis of hepatitis C
                   tidrug ⁃ resistant tuberculosis epidemics in Nanning City  sentinel surveillance in Jiangsu Province[J]. Chinese
                   from 2017 to 2021 based on SaTScan[J]. Journal of Pub⁃  Journal of AIDS & STD,2024,30(7):727-731
                   lic Health and Preventive Medicine,2024,35(2):17-20  [20]李晓印,赵艳秋,程晓庆,等. 2016-2022年江苏省苏州
             [12]World Health Organization. Global hepatitis report 2017  市丙型肝炎流行病学特征分析[J]. 疾病监测,2023,38
                  [R]. Geneva:WHO,2017                              (9):1067-1071
             [13]马一鸣,丁       勇. 我国 2012⁃2021 年 4 种肝炎流行趋势             LI X Y,ZHAO Y Q,CHENG X Q,et al. Analysis of epide⁃
                   的时间序列分析和预测[J]. 南京医科大学学报(自然                        miological characteristics of hepatitis C in Suzhou City,
                   科学版),2024,44(1):72-79                             Jiangsu Province from 2016 to 2022[J]. Disease Surveil⁃
                   MA Y M,DING Y. Time series analysis and forecasting of  lance,2023,38(9):1067-1071
                   four hepatitis epidemic trends in China from 2012 to  [21]周小毅,刘  凯,朱  平,等. 2013—2022 年南通市丙
                   2021[J]. Journal of Nanjing Medical University(Natural  型病毒性肝炎流行特征分析[J]. 医学动物防制,2025,
                   Sciences),2024,44(1):72-79                        41(2):114-118
             [14]卫生部. 关于扩大国家免疫规划实施方案的通知[EB/OL].                      ZHOU X Y,LIU K,ZHU P,et al. Analysis of the epidemi⁃
                  (2008 ⁃ 03 ⁃ 24)[2025 ⁃ 09 ⁃ 29].https://www.gov.cn/zwgk/  ological characteristics of viral hepatitis C in Nantong
                   2008⁃03/24/content_927256.htm                     City from 2013 to 2022[J]. Journal of Medical Pest Con⁃
                   The Ministry of Health.Notice on expanding the imple⁃  trol,2025,41(2):114-118
                   mentation plan of national immunization program disease  [22]许  纯,李锦成,杨文彬,等. 2012—2022 年扬州市丙
                   control and prevention[EB/OL].(2008⁃03⁃24)[2025⁃09⁃  肝流行特征及趋势分析[J]. 实用预防医学,2024,31
                   29].https://www.gov.cn/zwgk/2008⁃03/24/content_927256.  (10):1186-1190
                   htm                                               XU C,LI J C,YANG W B,et al. Analysis of epidemiologi⁃
             [15]韩思阳. 甲型肝炎的流行病特征及甲肝疫苗的保护效                            cal characteristics and trends of hepatitis C in Yangzhou
                   果研究进展[J]. 生物化工,2018,4(5):140-143                  City from 2012 to 2022[J]. Practical Preventive Medi⁃
                   HAN S Y. Research progress on epidemiological charac⁃  cine,2024,31(10):1186-1190
                   teristics of hepatitis A and protective efficacy of hepatitis  [23]中国国家药品监督管理局(NMPA)公告[EB/OL].(2012⁃
                   A vaccine[J]. Biological Chemical Engineering,2018,4  07⁃09). https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypgm⁃
                  (5):140-143                                        przh/ypgmprzhgg/ypgmpgjj/20120709120001450.html
             [16]黄琦敏,洪      镭,潘    俊,等. 2013—2017年南京市乙型              China National Medical Products Administration(NMPA)
                  病毒性肝炎流行病学特征[J]. 职业与健康,2019,35                      Announcement[EB/OL].(2012⁃07⁃09). https://www.nm⁃
                  (10):1353-1356                                     pa.gov.cn/xxgk/ggtg/ypggtg/ypgmprzh/ypgmprzhgg/ypgmp ⁃
                  HUANG Q M,HONG L,PAN J,et al. Epidemiological      gjj/20120709120001450.html
                  characteristics of viral hepatitis B in Nanjing City from  [24]修仕信. 东台地区戊型肝炎的疾病负担及免疫干预的
                  2013 to 2017[J]. Occupational and Health,2019,35   卫生经济学评价[D]. 南京:东南大学,2011
                  (10):1353-1356                                     XIU S X. Disease burden of hepatitis E and health eco⁃
             [17]杨永锐,沈       凌,吴文龙,等. DAA 治疗 HCV 单纯感染                nomic evaluation of immunization intervention in Dongtai
                   与 HCV/HIV 共感染的临床疗效[J]. 昆明医科大学学                    Region[D]. Nanjing:Southeast University,2011
                   报,2020,41(9):107-113                         [25]王   洁,刘效峰,吕      阳,等. 上海市宝山区戊型肝炎发
                   YANG Y R,SHEN L,WU W L,et al. Clinical efficacy of  病危险因素的病例对照分析[J]. 职业与健康,2022,38
                   DAA therapy for simple HCV infection and HCV/HIV co⁃                        (下转第240页)
   69   70   71   72   73   74   75   76   77   78   79